tradingkey.logo
搜尋

Halozyme Therapeutics Inc

HALO
添加自選
82.540USD
-0.760-0.91%
收盤 07-31 16:00美東報價延遲15分鐘
9.79B總市值
27.92本益比TTM

股東統計

更新時間: 5月14日 週四
更新時間: 5月14日 週四
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
9.73%
Vanguard Capital Management, LLC
4.44%
Vanguard Portfolio Management, LLC
4.43%
State Street Investment Management (US)
4.32%
Arrowstreet Capital, Limited Partnership
2.72%
其他
74.37%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
9.73%
Vanguard Capital Management, LLC
4.44%
Vanguard Portfolio Management, LLC
4.43%
State Street Investment Management (US)
4.32%
Arrowstreet Capital, Limited Partnership
2.72%
其他
74.37%
股東類型
持股股東
佔比
Investment Advisor
52.12%
Investment Advisor/Hedge Fund
38.27%
Research Firm
5.24%
Hedge Fund
5.07%
Pension Fund
3.05%
Bank and Trust
2.03%
Sovereign Wealth Fund
1.64%
Individual Investor
1.06%
Insurance Company
0.10%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
1232
138.78M
117.14%
+5.11M
2025Q4
1158
124.73M
106.06%
-3.59M
2025Q3
1096
120.60M
102.56%
-9.25M
2025Q2
1037
125.48M
107.21%
-10.05M
2025Q1
1043
127.91M
103.79%
-10.64M
2024Q4
999
127.73M
103.64%
-14.45M
2024Q3
953
129.39M
102.16%
-10.33M
2024Q2
905
126.24M
99.18%
-14.91M
2024Q1
870
127.71M
100.45%
-13.70M
2023Q4
850
128.82M
97.51%
-11.71M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
11.54M
9.74%
+154.62K
+1.36%
Dec 31, 2025
State Street Investment Management (US)
5.12M
4.32%
+102.47K
+2.04%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
3.22M
2.72%
-68.16K
-2.07%
Dec 31, 2025
William Blair Investment Management, LLC
1.84M
1.56%
+1.47M
+393.11%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.43M
2.05%
+1.91K
+0.08%
Dec 31, 2025
Snyder Capital Management, L.P.
2.40M
2.03%
-334.66K
-12.24%
Dec 31, 2025
Invesco Advisers, Inc.
2.23M
1.88%
+326.37K
+17.17%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Future Fund Long/Short ETF
4.62%
First Trust NYSE Arca Biotechnology Index Fund
3.42%
Congress SMid Growth ETF
2.79%
Invesco Biotechnology & Genome ETF
2.61%
Invesco S&P MidCap 400 GARP ETF
2.23%
Janus Henderson Small/Mid Cap Growth Alpha ETF
2.18%
Virtus LifeSci Biotech Products ETF
1.91%
Alpha Architect US Quantitative Value ETF
1.74%
State Street SPDR S&P Biotech ETF
1.69%
First Trust Health Care Alphadex Fund
1.55%
查看更多
Future Fund Long/Short ETF
佔比4.62%
First Trust NYSE Arca Biotechnology Index Fund
佔比3.42%
Congress SMid Growth ETF
佔比2.79%
Invesco Biotechnology & Genome ETF
佔比2.61%
Invesco S&P MidCap 400 GARP ETF
佔比2.23%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比2.18%
Virtus LifeSci Biotech Products ETF
佔比1.91%
Alpha Architect US Quantitative Value ETF
佔比1.74%
State Street SPDR S&P Biotech ETF
佔比1.69%
First Trust Health Care Alphadex Fund
佔比1.55%
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有